Manufacturer
CoreAge Rx — GLP-1 Support ↗
Starting $23.83 per bottle; three named species and two prebiotic ingredient amounts. Full strain identities, live-organism quantity and exact-formula GLP-1 outcome evidence not verified.
Checked 2026-09-27Where these
notes begin.
Public product records and primary references, with the limits of each kept in view.
Inspected image
CoreAge Rx — front bottle image ↗
30 capsules and a 36 mg blend statement. This front view is not a complete readable Supplement Facts panel and cannot establish CFU or AFU.
Checked 2026-09-26Manufacturer
Biocare — 30g Chocolate, 14 packets ↗
One-time $55.90; repeating options $47.52 every two weeks and $50.31 monthly or every two months. Enabled purchase control observed, not guaranteed stock or a delivered quote. California warning retained without an invented chemical or exposure.
Checked 2026-09-26Inspected label
Biocare — chocolate Supplement Facts ↗
59 g packet, 200 calories, 30 g protein, 6 g fiber and multiple micronutrients/additional ingredients. Full formulation outcomes in GLP-1 users not established by the panel.
Checked 2026-09-26Inspected label
Biocare — chocolate ingredients and allergens ↗
Milk and soy lecithin; bioengineered-food-ingredient statement. Other flavors and Biocare2 are outside this review.
Checked 2026-09-26Manufacturer
Benefiber — US Original powder ↗
Current page links the 6 g dietary-fiber serving record. No selected retailer price or clinical effect on GLP-1 adverse events verified.
Checked 2026-09-26Manufacturer PDF
Haleon — current Original powder label ↗
124-teaspoon bottle; 31 four-teaspoon servings; wheat dextrin; 6 g dietary fiber including 6 g soluble fiber. Artwork dated May 2025, accessed today. Gluten-free statement is not personal wheat-allergy clearance.
Checked 2026-09-26Manufacturer
GARD — standard IBgard product record ↗
Standard product separated from vitamin D version. Manufacturer claims and use directions are not individualized recommendations. Text and panel retrieved; rendered browser route did not expose the full page. Current retailer price unverified.
Checked 2026-09-26Inspected label
GARD — standard IBgard facts panel ↗
Two capsules, 180 mg peppermint oil; 24 servings in depicted 48-count pack. Gelatin listed; cool/dry storage and label declarations retained.
Checked 2026-09-26Manufacturer
GARD — frequently asked questions ↗
Medication/supplement consultation and formulation-handling details. Product-specific information, not clearance for GLP-1 symptoms.
Checked 2026-09-26Primary research abstract
Cash and colleagues — four-week peppermint-oil trial ↗
72 adults with IBS-D or IBS-M; total IBS symptom score improved more than placebo. Short duration, selected population and company-affiliated author; not a GLP-1 medication trial.
Checked 2026-09-26Primary research abstract
Weerts and colleagues — eight-week peppermint-oil trial ↗
Different release formulations; primary pain-response and overall-relief endpoints not significantly improved. Not represented as a direct test of the current IBgard package.
Checked 2026-09-26Public health
NCCIH — peppermint oil ↗
Evidence, formulation limitations and possible adverse effects including heartburn. Does not endorse a GLP-1 nausea treatment.
Checked 2026-09-26Public health
NIH ODS — probiotics ↗
Organism identity, condition-specific evidence, quantity, shelf life and safety context. Not validation of every finished blend.
Checked 2026-09-26Public health
NIH ODS — dietary supplements ↗
Whole-product review, healthcare discussion, quality and regulatory context.
Checked 2026-09-26Regulator
FDA — using dietary supplements ↗
Supplements are not approved before marketing for safety and effectiveness in the same way as drugs.
Checked 2026-09-26Regulator
FDA — food allergies ↗
Reading food-source and allergen statements; recognizing reactions and obtaining appropriate care.
Checked 2026-09-27Medicine reference
MedlinePlus — semaglutide injection ↗
Drug-specific precautions and symptoms requiring action. No individual medication changes inferred.
Checked 2026-09-27Medicine reference
MedlinePlus — tirzepatide injection ↗
Medicine-specific instructions and serious-symptom context. Not a supplement endorsement.
Checked 2026-09-26Public health
NIDDK — constipation symptoms and causes ↗
Multiple possible causes and warning signs. May 2018 clinical review date; current access does not imply new medical review.
Checked 2026-09-26Public health
NIDDK — nutrition for constipation ↗
Dietary context, gradual changes and individualized fluids. May 2018 clinical review date.
Checked 2026-09-26Public health
NIDDK — gastroparesis symptoms and causes ↗
Symptoms and care context for a specific condition; early fullness alone does not establish this diagnosis.
Checked 2026-09-26Public health
NIDDK — nutrition for gastroparesis ↗
Condition-specific nutrition guidance; not converted into a universal GLP-1 meal plan.
Checked 2026-09-26Manufacturer product record
Abbott Nutrition — Ensure Max Protein ↗
U.S. standard Milk Chocolate 11 fl oz nutrient and ingredient record; 150 calories, 30 g protein and 4 g fiber. Not the 42 g, HMB or caffeinated formula. No finished-formula GLP-1 outcome trial verified.
Checked 2026-09-27Manufacturer
Ensure — standard Milk Chocolate ↗
4 g fiber statement and formula-specific FAQ. Dynamic table placeholders were not used as data; the accessible Abbott professional and store tables supplied the full record. Energy survey footnote is not a GLP-1 clinical trial.
Checked 2026-09-27Manufacturer storefront
Abbott Store — standard Milk Chocolate, case of 12 ↗
Selected U.S. 11 fl oz Milk Chocolate, milk ingredients, 4 g fiber and full nutrient table. No selected price, checkout, delivered inventory or renewal total verified.
Checked 2026-09-27Public health
NIDDK — diarrhea symptoms and causes ↗
Adult warning signs, dehydration, causes and higher-risk groups. General symptom guidance does not identify a medication or supplement as the cause.
Checked 2026-09-27Public health
NIDDK — nutrition for diarrhea ↗
Acute-diarrhea food context including sugar alcohols, lactose and caffeine. Not a permanent exclusion diet or individualized GLP-1 care plan.
Checked 2026-09-27Public health
NIDDK — diagnosing diarrhea ↗
Clinical history, examinations and possible testing. September 2024 clinical review date is separate from current access.
Checked 2026-09-27Public health
NIH ODS — magnesium for consumers ↗
High magnesium intakes from supplements or medicines may cause diarrhea. Does not establish that any food containing magnesium caused a symptom.
Checked 2026-09-27Regulator
FDA — reporting a problem with dietary supplements ↗
Suspected serious supplement reactions, stopping the suspect supplement, Safety Reporting Portal and assistance links. Reporting does not replace care or direct prescription changes.
Checked 2026-09-27Regulator
FDA — reporting serious problems with medical products ↗
Voluntary consumer and professional MedWatch routes. Consumers can report without requiring their clinician to complete the report. No report was submitted.
Checked 2026-09-27